Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Non-Current Debt (2016 - 2021)

Creative Medical Technology Holdings (CELZ) has disclosed Non-Current Debt for 6 consecutive years, with $52582.0 as the latest value for Q2 2021.

  • On a quarterly basis, Non-Current Debt rose 18546.1% to $52582.0 in Q2 2021 year-over-year; TTM through Jun 2021 was $52582.0, a 18546.1% increase, with the full-year FY2020 number at $18782.0, up 22804.88% from a year prior.
  • Non-Current Debt was $52582.0 for Q2 2021 at Creative Medical Technology Holdings, up from $5082.0 in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $198082.0 in Q4 2018 to a low of $82.0 in Q4 2019.
  • A 5-year average of $35057.7 and a median of $11282.0 in 2020 define the central range for Non-Current Debt.
  • Peak YoY movement for Non-Current Debt: tumbled 99.96% in 2019, then skyrocketed 22804.88% in 2020.
  • Creative Medical Technology Holdings' Non-Current Debt stood at $25000.0 in 2017, then soared by 692.33% to $198082.0 in 2018, then crashed by 99.96% to $82.0 in 2019, then surged by 22804.88% to $18782.0 in 2020, then soared by 179.96% to $52582.0 in 2021.
  • Per Business Quant, the three most recent readings for CELZ's Non-Current Debt are $52582.0 (Q2 2021), $5082.0 (Q1 2021), and $18782.0 (Q4 2020).